サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446538

米国のウェアラブル医療機器市場規模、シェア、動向分析レポート：製品別、部位別、グレードタイプ別、流通チャネル別、用途別、セグメント予測、2024年～2030年

U.S. Wearable Medical Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices), By Site (Handheld), By Grade Type, By Distribution Channel, By Application, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 70 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国のウェアラブル医療機器市場規模、シェア、動向分析レポート：製品別、部位別、グレードタイプ別、流通チャネル別、用途別、セグメント予測、2024年～2030年
出版日: 2024年02月21日
発行: Grand View Research
ページ情報: 英文 70 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のウェアラブル医療機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国のウェアラブル医療機器市場規模は2030年までに468億9,000万米ドルに達し、2024年から2030年までのCAGRは23.4％で拡大すると予測されています。

慢性疾患の有病率の上昇、消費者の意識の高まり、技術の採用、規制当局の支援と承認プロセスが米国のウェアラブル医療機器市場の主要促進要因です。

市場情勢の中で、各社は研究開発に向けて多額の投資を行うと同時に、生産能力の強化に努めています。各社はウェアラブル医療機器の開発を追求し、競争力のある価格で消費者に提供しています。各社は顧客を惹きつけ、全体的な魅力を高めるために、最先端の健康機能を取り入れています。

米国では、ウェアラブル医療機器の採用が拡大しているが、その背景には、技術の進歩、ヘルスケア提供システムの変革、健康と福祉に対する消費者の高い関心、予防医療対策を優先する方向へのシフトなど、複数の要因があります。ウェアラブル医療機器はヘルスケアの変革期を先導し、患者が継続的に健康状態を追跡できるようにするとともに、医療従事者が貴重なリアルタイムデータにアクセスできるようにします。この革新的な技術は、よりオーダーメイドでプロアクティブなケアアプローチを促進します。さらに、ウェアラブル医療機器によって生成されるリアルタイムおよび過去の健康データのサイバーセキュリティが確認され、ハイエンドのデータプライバシーが維持されています。

米国のウェアラブル医療機器市場レポート・ハイライト

  • 製品別では、診断機器分野が市場を独占し、個別化医療、遠隔患者モニタリング、費用対効果に対する需要の高まりにより、2023年には61.3%のシェアを占めました。
  • 部位別では、ストラップ、クリップ、ブレスレット分野が予測期間中に最も速いCAGRで成長すると予測されています。靴用センサセグメントは予測期間に有利な成長が見込まれます。
  • 用途別では、在宅ヘルスケア分野が2023年に53.2％の最大市場収益シェアを占めました。これは、米国で糖尿病、喘息、心疾患を含む慢性疾患の有病率が上昇し、老年人口が増加していることに起因しています。
  • FDAはウェアラブル医療機器をその使用目的とリスクレベルに基づいて分類しています。フィットネストラッカーを含む低リスクの機器はクラスi医療機器に分類され、市販前承認（PMA）は必要ないです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のウェアラブル医療機器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国のウェアラブル医療機器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国のウェアラブル医療機器市場：タイプの推定・動向分析

  • タイプ市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 米国のタイプ別ウェアラブル医療機器市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 米国のウェアラブル医療機器市場：サイトの推定・動向分析

  • サイト市場シェア、2023年と2030年
  • セグメントダッシュボード
  • サイト別の米国のウェアラブル医療機器市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 米国のウェアラブル医療機器市場：アプリケーションの推定・動向分析

  • アプリケーション市場シェア、2023年と2030年
  • セグメントダッシュボード
  • アプリケーション別の米国のウェアラブル医療機器市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第7章 米国のウェアラブル医療機器市場：グレードタイプの推定・動向分析

  • グレードタイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 米国のウェアラブル医療機器市場のグレード別展望
  • 市場規模、予測および動向分析、2018年から2030年まで

第8章 米国のウェアラブル医療機器市場：流通チャネルの推定・動向分析

  • 流通チャネル市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 流通チャネル別の米国のウェアラブル医療機器市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
  • 企業プロファイル
    • Koninklijke Philips NV
    • Fitbit
    • Garmin
    • Medtronic
    • Omron Corp.
    • Withings
    • Polar Electro
    • Everist Genomics
    • Intelesens Ltd.
    • Sotera Wireless
    • Abbvie Inc.
    • Apple Inc.
    • Vital Connect
    • Basic Science
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. wearable medical devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. wearable medical devices market, by diagnostic devices type, 2018 - 2030 (USD Million)
  • Table 4 U.S. wearable medical devices market, by vital sign monitoring device type, 2018 - 2030 (USD Million)
  • Table 5 U.S. wearable medical devices market, by sleep monitoring device type, 2018 - 2030 (USD Million)
  • Table 6 U.S. wearable medical devices market, by neuromonitoring device type, 2018 - 2030 (USD Million)
  • Table 7 U.S. wearable medical devices market, by therapeutic device type, 2018 - 2030 (USD Million)
  • Table 8 U.S. wearable medical devices market, by pain management device type, 2018 - 2030 (USD Million)
  • Table 9 U.S. wearable medical devices market, by insulin management device type, 2018 - 2030 (USD Million)
  • Table 10 U.S. wearable medical devices market, by other insulin management devices type, 2018 - 2030 (USD Million)
  • Table 11 U.S. wearable medical devices market, by rehabilitation device type, 2018 - 2030 (USD Million)
  • Table 12 U.S. wearable medical devices market, by respiratory therapy device type, 2018 - 2030 (USD Million)
  • Table 13 U.S. wearable medical devices market, by other insulin management devices type, 2018 - 2030 (USD Million)
  • Table 14 U.S. wearable medical devices market, by other insulin management devices type, 2018 - 2030 (USD Million)
  • Table 15 U.S. wearable medical devices market, by site, 2018 - 2030 (USD Million)
  • Table 16 U.S. wearable medical devices market, by application, 2018 - 2030 (USD Million)
  • Table 17 U.S. wearable medical devices market, by grade type, 2018 - 2030 (USD Million)
  • Table 18 U.S. wearable medical devices market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Wearable Medical Devices Market: market outlook
  • Fig. 9 Wearable devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. wearable medical devices market driver impact
  • Fig. 14 U.S. wearable medical devices market restraint impact
  • Fig. 15 U.S. wearable medical devices market strategic initiatives analysis
  • Fig. 16 U.S. wearable medical devices market: Product movement analysis
  • Fig. 17 U.S. wearable medical devices market: Site outlook and key takeaways
  • Fig. 18 Diagnostic devices market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
  • Fig. 19 Therapeutic devices estimate and forecasts, 2018 - 2030 (USD Million) (USD Million)
  • Fig. 20 U.S. wearable medical devices market: Site movement Analysis
  • Fig. 21 U.S. Wearable Medical Devices Market: Site outlook and key takeaways
  • Fig. 22 Handheld market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Headband market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Clip/strap/bracelet market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Shoe sensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. wearable medical devices market: application movement analysis
  • Fig. 28 U.S. wearable medical devices market: application outlook and key takeaways
  • Fig. 29 Sports & fitness market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Remote patient monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Home Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. wearable medical devices market: grade type movement analysis
  • Fig. 33 U.S. wearable medical devices market: grade type outlook and key takeaways
  • Fig. 34 Consumer grade wearable medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Clinical wearable medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. wearable medical devices market: distribution channel movement analysis
  • Fig. 37 U.S. wearable medical devices market: distribution channel outlook and key takeaways
  • Fig. 38 Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Online channel market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Hypermarkets market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-198-6

U.S. Wearable Medical Devices Market Growth & Trends:

The U.S. wearable medical devices market size is expected to reach USD 46.89 billion by 2030 and is anticipated to expand at a CAGR of 23.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, growing consumer awareness, adoption of technology, and regulatory support and approval processes are the key drivers of the U.S. wearable medical devices market.

Within the market landscape, the players are allocating substantial investments towards research and development, simultaneously striving to enhance their production capacities. The companies are pursuing the development of wearable medical devices, offering them to consumers at competitive prices. They are incorporating cutting-edge health features to attract customers and enhance overall appeal.

In the U.S., the growing adoption of wearable medical devices is fueled by multiple factors, including technological advancements, transforming healthcare delivery systems, high consumer interest in health and well-being, and a shift towards prioritizing preventive care measures. Wearable medical devices spearhead a transformative era in healthcare, enabling patients to continuously track their health status and granting healthcare professionals access to invaluable real-time data. This innovative technology facilitates more tailored and proactive care approaches. Furthermore, high-end data privacy is maintained, confirming the cyber security of the real-time and past health data generated by wearable medical devices.

U.S. Wearable Medical Devices Market Report Highlights:

  • Based on product, the diagnostic devices segment dominated the market and accounted for a share of 61.3% in 2023 due to growing demand for personalized medicine, remote patient monitoring, and Cost-effectiveness
  • Based on site, the strap, clip, and bracelet segment is expected to grow at the fastest CAGR over the forecast period. The shoe sensors segment is anticipated to witness lucrative growth over the forecast period
  • Based on application, the home healthcare segment dominated with the largest market revenue share of 53.2% in 2023. This is attributable to the rising prevalence of chronic diseases involving diabetes, asthma, and cardiac diseases and the rising geriatric population in the U.S.
  • The FDA classifies wearable medical devices based on their intended use and level of risk. Low-risk devices involving fitness trackers are classified as Class I medical devices and do not require pre-market approval (PMA)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Site
    • 1.2.3. Application
    • 1.2.4. Grade type
    • 1.2.5. Distribution channel
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Site outlook
    • 2.2.3. Application outlook
    • 2.2.4. Grade Type outlook
    • 2.2.5. Distribution channel
  • 2.3. Competitive Insights

Chapter 3. U.S. Wearable Medical Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Wearable Medical Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Wearable Medical Devices Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Wearable Medical Devices Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Diagnostic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Therapeutic Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Wearable Medical Devices Market: Site Estimates & Trend Analysis

  • 5.1. Site Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Wearable Medical Devices Market by Site Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Handheld
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Headband
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. Clip/Strap/Bracelet
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Shoe Sensors
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Wearable Medical Devices Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Wearable Medical Devices Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Sports & Fitness
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. Remote Patient Monitoring
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.3. Home Healthcare
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. U.S. Wearable Medical Devices Market: Grade Type Estimates & Trend Analysis

  • 7.1. Grade Type Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Wearable Medical Devices Market by Grade Type Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Consumer-grade Wearable Medical Devices
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.2. Clinical Wearable Medical Devices
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. U.S. Wearable Medical Devices Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Distribution Channel Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. U.S. Wearable Medical Devices Market by Distribution Channel Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Pharmacy
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.2. Online Channels
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.3. Hypermarkets
      • 8.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Koninklijke Philips N.V.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Fitbit
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Garmin
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Medtronic
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Omron Corp.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Withings
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Polar Electro
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Everist Genomics
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Intelesens Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Sotera Wireless
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Abbvie Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Apple Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Vital Connect
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Basic Science
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives